{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:00:12Z","timestamp":1790312412152,"version":"4.1.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>\n                    Pathological complete response (pCR) after neoadjuvant therapy is an important response endpoint in breast cancer. We investigated whether routinely generated pretreatment core biopsy pathology reports could support pCR prediction and whether clinical, preoperative laboratory, and treatment information provided incremental predictive value. This single-center retrospective model-development study included 171 patients with breast cancer who underwent core biopsy, neoadjuvant therapy, and surgery at Xinxiang Central Hospital between March 1, 2016, and January 1, 2026; 64 achieved pCR and 107 did not. We converted 361 pretreatment pathology files to patient-level text, extracted structured pathology phenotypes with a rule-based pipeline, and represented report text with character\/marker n-gram term frequency-inverse document frequency followed by singular value decomposition. Five primary elastic net logistic regression models were assessed using 20 repeats of stratified 5-fold cross-validation, with all learned preprocessing confined to training folds. The clinical-laboratory model showed weak discrimination (area under the receiver operating characteristic curve [AUC] 0.420, 95% confidence interval [CI] 0.326-0.509). The structured pathology and report text models achieved AUCs of 0.738 (95% CI 0.664-0.810) and 0.689 (95% CI 0.606-0.767), respectively. Pathology fusion achieved an AUC of 0.747 (95% CI 0.672-0.815; Brier score 0.200, 95% CI 0.175-0.226). Adding clinical-laboratory variables did not improve AUC (multimodal AUC 0.733, 95% CI 0.656-0.805; difference vs. pathology fusion \u22120.014, 95% CI -0.048 to 0.017; P\u00a0=\u00a00.388). In a\n                    <jats:italic>post-hoc<\/jats:italic>\n                    secondary analysis, adding standardized regimen components to pathology fusion yielded an AUC of 0.757 (95% CI 0.679-0.824) and an AUC increase of 0.009 (95% CI \u22120.019 to 0.037; P\u00a0=\u00a00.487). The tested frozen BGE, Chinese RoBERTa, and ERNIE-Health embeddings did not outperform the lexical text representation. Among 20 audited image-only cases, OCR character accuracy was 98.72%; across 40 audited cases, critical pathology-field agreement ranged from 95.0% to 100%. Pretreatment pathology reports carried most of the observed predictive signal, whereas the incremental value of treatment information was small and imprecisely estimated. Independent external validation is required before clinical use.\n                  <\/jats:p>","DOI":"10.3389\/fonc.2026.1909071","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:27:48Z","timestamp":1790310468000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of pathological complete response after neoadjuvant therapy in breast cancer using pretreatment core biopsy pathology reports: a pathology-report-driven model with exploratory clinical-laboratory fusion"],"prefix":"10.3389","volume":"16","author":[{"given":"Rui","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Xinxiang Central Hospital","place":["Xinxiang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxia","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Xinxiang Central Hospital","place":["Xinxiang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pain Medicine, Xinxiang Central Hospital","place":["Xinxiang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Xinxiang Central Hospital","place":["Xinxiang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.2779","article-title":"Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL - CALGB 150007\/150012, ACRIN 6657","volume":"30","author":"Esserman","year":"2012","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis","volume":"26","author":"Spring","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4801-3","article-title":"Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy","volume":"170","author":"Haque","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/tomography8060232","article-title":"Deep learning prediction of pathologic complete response in breast cancer using MRI and other clinical data: a systematic review","volume":"8","author":"Khan","year":"2022","journal-title":"Tomography"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06310-8","article-title":"Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer","volume":"189","author":"Kim","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2023.26.e14","article-title":"Development and external validation of a machine learning model to predict pathological complete response after neoadjuvant chemotherapy in breast cancer","volume":"26","author":"Jung","year":"2023","journal-title":"J Breast Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13058-024-01905-7","article-title":"Predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer using a machine learning approach","volume":"26","author":"Zhao","year":"2024","journal-title":"Breast Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.1038\/s41598-022-13917-4","article-title":"Quantitative digital histopathology and machine learning to predict pathological complete response to chemotherapy in breast cancer patients using pre-treatment tumor biopsies","volume":"12","author":"Saednia","year":"2022","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/mp.16574","article-title":"A hierarchical self-attention-guided deep learning framework to predict breast cancer response to chemotherapy using pre-treatment tumor biopsies","volume":"50","author":"Saednia","year":"2023","journal-title":"Med Phys"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-023-00535-0","article-title":"Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial","volume":"9","author":"Fanucci","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10549-024-07539-9","article-title":"Predicting nodal response to neoadjuvant treatment in breast cancer with core biopsy biomarkers of tumor microenvironment using data mining","volume":"210","author":"Pislar","year":"2025","journal-title":"Breast Cancer Res Treat"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.21037\/gs-2025-7","article-title":"Factors influencing the efficacy of neoadjuvant chemotherapy for HER-2-low early-stage breast cancer and a predictive model for pathological complete response","volume":"14","author":"Duan","year":"2025","journal-title":"Gland Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"18800","DOI":"10.1038\/s41598-021-98408-8","article-title":"Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer","volume":"11","author":"Joo","year":"2021","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1186\/s12967-025-06617-w","article-title":"Attention-based multimodal deep learning for interpretable and generalizable prediction of pathological complete response in breast cancer","volume":"23","author":"Nishizawa","year":"2025","journal-title":"J Transl Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1186\/s12885-021-08458-4","article-title":"Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy","volume":"21","author":"Dong","year":"2021","journal-title":"BMC Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"12123","DOI":"10.1038\/s41598-024-63096-7","article-title":"The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy","volume":"14","author":"Yildirim","year":"2024","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000001034","article-title":"Preoperative systemic inflammation response index: clinicopathologic predictor of pathological complete response in HER2-positive breast cancer patients receiving neoadjuvant systemic therapy","volume":"87","author":"Wu","year":"2024","journal-title":"J Chin Med Assoc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1437140","article-title":"The role of systemic immune-inflammation index in predicting pathological complete response of breast cancer after neoadjuvant therapy and the establishment of related predictive model","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/s12905-024-03400-9","article-title":"Development of predictive models for pathological response status in breast cancer after neoadjuvant therapy based on peripheral blood inflammatory indexes","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Womens Health"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.21.00017","article-title":"Customizable natural language processing biomarker extraction tool","volume":"5","author":"Holmes","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2021.692077","article-title":"Machine learning-based extraction of breast cancer receptor status from bilingual free-text pathology reports","volume":"3","author":"Pironet","year":"2021","journal-title":"Front Digit Health"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6157861","article-title":"Rule-based information extraction from free-text pathology reports reveals trends in South African female breast cancer molecular subtypes and Ki67 expression","volume":"2022","author":"Achilonu","year":"2022","journal-title":"BioMed Res Int"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3857\/roj.2023.00633","article-title":"Developing prompts from large language model for extracting clinical information from pathology and ultrasound reports in breast cancer","volume":"41","author":"Choi","year":"2023","journal-title":"Radiat Oncol J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"39855","DOI":"10.1038\/s41598-025-23461-6","article-title":"Development of a machine learning model for automatic data extraction from breast cancer pathology reports","volume":"15","author":"Kwok","year":"2025","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/CCI-25-00133","article-title":"Development and assessment of a pipeline for extracting structured data from free-text medical reports using a large language model","volume":"10","author":"Joseph","year":"2026","journal-title":"JCO Clin Cancer Inform"},{"key":"B28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12911-024-02677-y","article-title":"Validation of large language models for detecting pathologic complete response in breast cancer using population-based pathology reports","volume":"24","author":"Cheligeer","year":"2024","journal-title":"BMC Med Inform Decis Mak"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2309.07597","DOI":"10.48550\/arXiv.2309.07597","article-title":"C-pack: packaged resources to advance general chinese embedding","author":"Xiao","year":"2023","journal-title":"arXiv [Preprint]"},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.18653\/v1\/2020.findings-emnlp.58","article-title":"Revisiting pre-trained models for Chinese natural language processing","volume-title":"Findings of the Association for Computational Linguistics: EMNLP 2020","author":"Cui","year":"2020"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2110.07244","DOI":"10.1145\/3626772.3657878","article-title":"Building Chinese biomedical language models via multi-level text discrimination","author":"Wang","year":"2021","journal-title":"arXiv [Preprint]"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"B33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1198\/000313001300339897","article-title":"The abuse of power: the pervasive fallacy of power calculations for data analysis","volume":"55","author":"Hoenig","year":"2001","journal-title":"Am Stat"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1909071\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:27:49Z","timestamp":1790310469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1909071\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":34,"alternative-id":["10.3389\/fonc.2026.1909071"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1909071","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1909071"}}